10x Genomics (TXG) Non Operating Income (2018 - 2026)

10x Genomics (TXG) has 9 years of Non Operating Income data on file, last reported at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 27.88% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 2.47% YoY), and the FY2025 full-year result was $21.1 million, up 25.03% from the prior year.
• Non Operating Income retreated to $4.2 million in Q1 2026, from $4.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8.6 million in Q4 2023 to a low of -$714000.0 in Q2 2022.
• A 5-year average of $3.8 million and a median of $4.0 million in 2025 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income slumped 292.97% in 2022 and soared 7923.08% in 2023, its largest moves.
• Tracing TXG's Non Operating Income over 5 years: stood at $6.7 million in 2022, then advanced by 28.5% to $8.6 million in 2023, then plunged by 83.02% to $1.5 million in 2024, then soared by 198.01% to $4.3 million in 2025, then fell by 3.43% to $4.2 million in 2026.
• Business Quant data shows TXG's Non Operating Income at $4.2 million in Q1 2026, $4.3 million in Q4 2025, and $4.0 million in Q3 2025.